Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation

BACKGROUND: The prognosis of peritoneal carcinomatosis in patients with lung cancer is poor. However, some cases of peritoneal carcinomatosis from lung cancer harboring specific gene alterations have responded to molecular targeted drugs. B-Raf proto-oncogene (BRAF) mutations occur in about 2–4% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagami, Yuri, Nakahara, Yoshiro, Manabe, Hideaki, Yamamoto, Hiroki, Otani, Sakiko, Sato, Takashi, Igawa, Satoshi, Kubota, Masaru, Sasaki, Jiichiro, Naoki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664913/
https://www.ncbi.nlm.nih.gov/pubmed/36388158
http://dx.doi.org/10.2147/OTT.S375246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664913/
https://www.ncbi.nlm.nih.gov/pubmed/36388158
http://dx.doi.org/10.2147/OTT.S375246

Ejemplares similares